This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Paul Thomas
pgtimmune.bsky.social
did:plc:kcdheikds6a2gnst5ify3yps
Two complementary studies from our group out today: a therapeutic peptide vaccine trial for fibrolamellar carcinoma (FLC) & TIRTL-Seq, our robust method for deep quantitative paired TCR sequencing a🧵w/ @markyarchoan.bsky.social & @pogorely.bsky.social https://www.nature.com/articles/s41592-025-02907-9
2025-11-24T21:38:10.832Z